BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36502446)

  • 1. Effect of miR-27b on the proliferation and apoptosis of diffuse large b-cell lymphoma cells by targeting the regulation of MET/PI3K/AKT pathway.
    Zhang R; Huang T; Li J; Zhou H; Wang X
    Discov Oncol; 2022 Dec; 13(1):137. PubMed ID: 36502446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Geniposide inhibits proliferation and induces apoptosis of diffuse large B-cell lymphoma cells by inactivating the HCP5/miR-27b-3p/MET axis.
    Hu L; Zhao J; Liu Y; Liu X; Lu Q; Zeng Z; Zhu L; Tong X; Xu Q
    Int J Med Sci; 2020; 17(17):2735-2743. PubMed ID: 33162801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HDAC6 regulates microRNA-27b that suppresses proliferation, promotes apoptosis and target MET in diffuse large B-cell lymphoma.
    Jia YJ; Liu ZB; Wang WG; Sun CB; Wei P; Yang YL; You MJ; Yu BH; Li XQ; Zhou XY
    Leukemia; 2018 Mar; 32(3):703-711. PubMed ID: 29135973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA CHROMR/miR-27b-3p/MET axis promotes the proliferation, invasion, and contributes to rituximab resistance in diffuse large B-cell lymphoma.
    Liu C; Zhao X; Wang Z; Zhang C; Zheng W; Zhu X; Zhang D; Gong T; Zhao H; Li F; Guan T; Guo X; Zhang H; Yu B
    J Biol Chem; 2024 Mar; 300(3):105762. PubMed ID: 38367665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of mir-27b promotes angiogenesis and fibroblast activation through activating PI3K/AKT signaling pathway.
    Sun F; Bi Q; Wang X; Liu J
    Wound Repair Regen; 2020 Jan; 28(1):39-48. PubMed ID: 31587435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma.
    Go H; Jang JY; Kim PJ; Kim YG; Nam SJ; Paik JH; Kim TM; Heo DS; Kim CW; Jeon YK
    Oncotarget; 2015 Jun; 6(17):15035-49. PubMed ID: 25909227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CircRNA_OTUD7A upregulates FOXP1 expression to facilitate the progression of diffuse large B-cell lymphoma via acting as a sponge of miR-431-5p.
    Liu W; Lei L; Liu X; Ye S
    Genes Genomics; 2021 Jun; 43(6):653-667. PubMed ID: 33830472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA NORAD Mediates the Proliferation and Apoptosis of Diffuse Large-B-Cell Lymphoma via Regulation of miR-345-3p/TRAF6 Axis.
    Li Y; Lv Y; Wang J; Zhu X; Chen J; Zhang W; Wang C; Jiang L
    Arch Med Res; 2022 Apr; 53(3):271-279. PubMed ID: 35164979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of miR-126 in Diffuse Large B-Cell Lymphoma and Its Biological Function].
    Qiu C; Zhang QH; Wang GG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1415-1422. PubMed ID: 36208243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of miR-122-5p regulating the activation of PI3K-Akt-mTOR signaling pathway on the cell proliferation and apoptosis of osteosarcoma cells through targeting TP53 gene.
    Li KW; Wang SH; Wei X; Hou YZ; Li ZH
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12655-12666. PubMed ID: 33378012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CAPG facilitates diffuse large B-cell lymphoma cell progression through PI3K/AKT signaling pathway.
    Wang G; Liu H; An L; Hou S; Zhang Q
    Hum Immunol; 2022 Dec; 83(12):832-842. PubMed ID: 36244872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
    Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D
    Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway.
    Pei Q; Liu GS; Li HP; Zhang Y; Xu XC; Gao H; Zhang W; Li T
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9871-9881. PubMed ID: 31799655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-214 prevents the progression of diffuse large B-cell lymphoma by targeting PD-L1.
    Sun JR; Zhang X; Zhang Y
    Cell Mol Biol Lett; 2019; 24():68. PubMed ID: 31844419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of miR-182 on hepatic fibrosis induced by Schistosomiasis japonica by targeting FOXO1 through PI3K/AKT signaling pathway.
    Huang Y; Fan X; Tao R; Song Q; Wang L; Zhang H; Kong H; Huang J
    J Cell Physiol; 2018 Oct; 233(10):6693-6704. PubMed ID: 29323718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of MicroRNA-27b Inhibits Proliferation, Migration, and Invasion via Suppression of MET Expression.
    Zhou H; Liu Y; Xiao L; Hu Z; Xia K
    Oncol Res; 2017 Jan; 25(1):147-154. PubMed ID: 28081743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined targeting of vascular endothelial growth factor C (VEGFC) and P65 using miR-27b-3p agomir and lipoteichoic acid in the treatment of gastric cancer.
    Cui Y; Huang S; Cao J; Ye J; Huang H; Liao D; Yang Y; Chen W; Pu R
    J Gastrointest Oncol; 2021 Feb; 12(1):121-132. PubMed ID: 33708430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LINC00520 targeting miR-27b-3p regulates OSMR expression level to promote acute kidney injury development through the PI3K/AKT signaling pathway.
    Tian X; Ji Y; Liang Y; Zhang J; Guan L; Wang C
    J Cell Physiol; 2019 Aug; 234(8):14221-14233. PubMed ID: 30684280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-200b-5p inhibits proliferation of ovarian cancer cells by targeting ATAD2 and regulating PI3K/AKT signaling pathway.
    Wang AQ; Lv M; Xu YH; Xie PM; Dong YY
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):9860-9868. PubMed ID: 33090389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.